105 related articles for article (PubMed ID: 15743206)
21. 5-pyrrolidinylsulfonyl isatins as a potential tool for the molecular imaging of caspases in apoptosis.
Kopka K; Faust A; Keul P; Wagner S; Breyholz HJ; Höltke C; Schober O; Schäfers M; Levkau B
J Med Chem; 2006 Nov; 49(23):6704-15. PubMed ID: 17154501
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of a potent and selective peptidomimetic inhibitor of caspase-3.
Micale N; Vairagoundar R; Yakovlev AG; Kozikowski AP
J Med Chem; 2004 Dec; 47(26):6455-8. PubMed ID: 15588079
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and caspase-3 inhibitory activity of 8-sulfonyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolines.
Kravchenko DV; Kysil VM; Tkachenko SE; Maliarchouk S; Okun IM; Ivachtchenko AV
Farmaco; 2005 Oct; 60(10):804-9. PubMed ID: 16182295
[TBL] [Abstract][Full Text] [Related]
24. Structure-based discovery of a new affinity ligand to pancreatic alpha-amylase.
Westerfors M; Tedebark U; Andersson HO; Ohrman S; Choudhury D; Ersoy O; Shinohara Y; Axén A; Carredano E; Baumann H
J Mol Recognit; 2003; 16(6):396-405. PubMed ID: 14732931
[TBL] [Abstract][Full Text] [Related]
25. N-(thiazol-2-yl)-2-thiophene carboxamide derivatives as Abl inhibitors identified by a pharmacophore-based database screening of commercially available compounds.
Manetti F; Falchi F; Crespan E; Schenone S; Maga G; Botta M
Bioorg Med Chem Lett; 2008 Aug; 18(15):4328-31. PubMed ID: 18621522
[TBL] [Abstract][Full Text] [Related]
26. In silico discovery of 2-amino-4-(2,4-dihydroxyphenyl)thiazoles as novel inhibitors of DNA gyrase B.
Brvar M; Perdih A; Oblak M; Masic LP; Solmajer T
Bioorg Med Chem Lett; 2010 Feb; 20(3):958-62. PubMed ID: 20045642
[TBL] [Abstract][Full Text] [Related]
27. IKKbeta inhibitors identification part I: homology model assisted structure based virtual screening.
Nagarajan S; Doddareddy Mr; Choo H; Cho YS; Oh KS; Lee BH; Pae AN
Bioorg Med Chem; 2009 Apr; 17(7):2759-66. PubMed ID: 19285872
[TBL] [Abstract][Full Text] [Related]
28. Computational studies of epidermal growth factor receptor: docking reliability, three-dimensional quantitative structure-activity relationship analysis, and virtual screening studies.
La Motta C; Sartini S; Tuccinardi T; Nerini E; Da Settimo F; Martinelli A
J Med Chem; 2009 Feb; 52(4):964-75. PubMed ID: 19170633
[TBL] [Abstract][Full Text] [Related]
29. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
[TBL] [Abstract][Full Text] [Related]
30. Protein secondary structure prediction with dihedral angles.
Wood MJ; Hirst JD
Proteins; 2005 May; 59(3):476-81. PubMed ID: 15778963
[TBL] [Abstract][Full Text] [Related]
31. In silico chemical library screening and experimental validation of a novel 9-aminoacridine based lead-inhibitor of human S-adenosylmethionine decarboxylase.
Brooks WH; McCloskey DE; Daniel KG; Ealick SE; Secrist JA; Waud WR; Pegg AE; Guida WC
J Chem Inf Model; 2007; 47(5):1897-905. PubMed ID: 17676832
[TBL] [Abstract][Full Text] [Related]
32. Structure-based pharmacophore identification of new chemical scaffolds as non-nucleoside reverse transcriptase inhibitors.
Barreca ML; De Luca L; Iraci N; Rao A; Ferro S; Maga G; Chimirri A
J Chem Inf Model; 2007; 47(2):557-62. PubMed ID: 17274611
[TBL] [Abstract][Full Text] [Related]
33. Discovery of novel PRL-3 inhibitors based on the structure-based virtual screening.
Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ
Bioorg Med Chem Lett; 2008 Apr; 18(7):2250-5. PubMed ID: 18358718
[TBL] [Abstract][Full Text] [Related]
34. Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.
Rella M; Rushworth CA; Guy JL; Turner AJ; Langer T; Jackson RM
J Chem Inf Model; 2006; 46(2):708-16. PubMed ID: 16563001
[TBL] [Abstract][Full Text] [Related]
35. Isatin sulfonamide analogs containing a Michael addition acceptor: a new class of caspase 3/7 inhibitors.
Chu W; Rothfuss J; d'Avignon A; Zeng C; Zhou D; Hotchkiss RS; Mach RH
J Med Chem; 2007 Jul; 50(15):3751-5. PubMed ID: 17585855
[TBL] [Abstract][Full Text] [Related]
36. Improved lead-finding for kinase targets using high-throughput docking.
McInnes C
Curr Opin Drug Discov Devel; 2006 May; 9(3):339-47. PubMed ID: 16729730
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel falcipain-2 inhibitors as potential antimalarial agents through structure-based virtual screening.
Li H; Huang J; Chen L; Liu X; Chen T; Zhu J; Lu W; Shen X; Li J; Hilgenfeld R; Jiang H
J Med Chem; 2009 Aug; 52(15):4936-40. PubMed ID: 19586036
[TBL] [Abstract][Full Text] [Related]
38. Structure-based tailoring of compound libraries for high-throughput screening: discovery of novel EphB4 kinase inhibitors.
Kolb P; Kipouros CB; Huang D; Caflisch A
Proteins; 2008 Oct; 73(1):11-8. PubMed ID: 18384152
[TBL] [Abstract][Full Text] [Related]
39. Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening.
Franke L; Schwarz O; Müller-Kuhrt L; Hoernig C; Fischer L; George S; Tanrikulu Y; Schneider P; Werz O; Steinhilber D; Schneider G
J Med Chem; 2007 May; 50(11):2640-6. PubMed ID: 17461565
[TBL] [Abstract][Full Text] [Related]
40. Conformationally restricted hydantoin-based peptidomimetics as inhibitors of caspase-3 with basic groups allowed at the S3 enzyme subsite.
Vázquez J; García-Jareño A; Mondragón L; Rubio-Martinez J; Pérez-Payá E; Albericio F
ChemMedChem; 2008 Jun; 3(6):979-85. PubMed ID: 18393268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
